Cargando…
RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
BACKGROUND: Currently, ribosome-binding protein 1 (RRBP1) is considered to be a novel oncogene that is overexpressed in colorectal cancer, lung cancer, mammary cancer, esophageal cancer and other carcinomas. However, the relationship between RRBP1 and endometrioid-type endometrial carcinoma (EC) rem...
Autores principales: | Liu, Shuang, Lin, Mu, Ji, Hongying, Ding, Jing, Zhu, Jiaqi, Ma, Rong, Meng, Fanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347782/ https://www.ncbi.nlm.nih.gov/pubmed/30684972 http://dx.doi.org/10.1186/s13000-019-0784-6 |
Ejemplares similares
-
Expression of RRBP1 in epithelial ovarian cancer and its clinical significance
por: Ma, Jing, et al.
Publicado: (2019) -
High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer
por: Liu, Shuang, et al.
Publicado: (2019) -
Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer
por: Telikicherla, Deepthi, et al.
Publicado: (2012) -
RRBP1 is highly expressed in prostate cancer and correlates with prognosis
por: Li, Tieqiu, et al.
Publicado: (2019) -
Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients
por: Cheng, Li, et al.
Publicado: (2019)